These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8261417)
1. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Waber PG; Chen J; Nisen PD Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417 [TBL] [Abstract][Full Text] [Related]
2. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044 [TBL] [Abstract][Full Text] [Related]
3. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877 [TBL] [Abstract][Full Text] [Related]
4. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat. Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505 [TBL] [Abstract][Full Text] [Related]
6. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230 [TBL] [Abstract][Full Text] [Related]
7. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas. Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248 [TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Reifenberger G; Liu L; Ichimura K; Schmidt EE; Collins VP Cancer Res; 1993 Jun; 53(12):2736-9. PubMed ID: 8504413 [TBL] [Abstract][Full Text] [Related]
9. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188 [TBL] [Abstract][Full Text] [Related]
11. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647 [TBL] [Abstract][Full Text] [Related]
12. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391 [TBL] [Abstract][Full Text] [Related]
13. Amplification of a gene encoding a p53-associated protein in human sarcomas. Oliner JD; Kinzler KW; Meltzer PS; George DL; Vogelstein B Nature; 1992 Jul; 358(6381):80-3. PubMed ID: 1614537 [TBL] [Abstract][Full Text] [Related]
14. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888 [TBL] [Abstract][Full Text] [Related]
16. MDM2 gene amplification in metastatic osteosarcoma. Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741 [TBL] [Abstract][Full Text] [Related]
17. p53 and MDM2 expression in oral squamous cell carcinoma. Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE Oncology; 1996; 53(4):308-12. PubMed ID: 8692535 [TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Kessis TD; Slebos RJ; Han SM; Shah K; Bosch XF; Muñoz N; Hedrick L; Cho KR Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255 [TBL] [Abstract][Full Text] [Related]
19. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665 [TBL] [Abstract][Full Text] [Related]
20. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance]. Zhang J; Liu H; Li S; Gu C Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]